HIV drug resistance in persons initiating or reinitiating first‐line antiretroviral therapy in Paraguay: Results of a National Patient Survey-Reference-Cited by-同舟云学术

HIV drug resistance in persons initiating or reinitiating first‐line antiretroviral therapy in Paraguay: Results of a National Patient Survey

Published:2022-06-30 Issue:10 Volume:94 Page:5061-5065
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:Journal of Medical Virology

Author:

Aguilar Gloria¹,Truong Hong‐Ha M.²,Ovelar Patricia¹,Samudio Tania¹,Lopez Gladys¹,García‐Morales Claudia³,Tapia‐Trejo Daniela³,López‐Sánchez Dulce M.³,Ávila‐Ríos Santiago³,Giron Amalia⁴,De Arias Antonieta R.⁵,Rios‐Gonzalez Carlos⁶,McFarland Willi⁷

Affiliation:

1. National Control Program for HIV/AIDS/STI República del Paraguay Ministry of Public Health and Social Welfare Asunción Paraguay

2. Department of Medicine, Center for Public Health Research University of California San Francisco California USA

3. Centre for Research in Infectious Diseases National Institute of Respiratory Diseases Mexico City Mexico

4. Department of Global HIV, Hepatitis and STI Programmes World Health Organization Geneva Switzerland

5. Centro para el Desarrollo de la Investigación Científica Asunción Paraguay

6. Direccion de Investigacion, Facultad de Ciencias Medicas Universidad Nacional de Caaguazú Coronel Oviedo Paraguay

7. Center for Public Health Research San Francisco Department of Public Health San Francisco California USA

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.27933

Reference20 articles.

1. Impact of HIV Drug Resistance on HIV/AIDS-Associated Mortality, New Infections, and Antiretroviral Therapy Program Costs in Sub–Saharan Africa

2. World Health Organization. Guidelines on the public health response to pretreatment HIV drug resistance. Accessed September 28 2021. https://www.who.int/publications/i/item/9789241550055

3. World Health Organization. Surveillance of HIV drug resistance in populations initiating antiretroviral therapy ‐ pre‐treatment HIV drug resistance. Accessed September 28 2021.https://www.who.int/publications/i/item/9789241507196

4. World Health Organization. Global action plan on HIV drug resistance 2017–2021. Accessed June 3 2022.http://apps.who.int/iris/bitstream/handle/10665/255883/9789241512848-eng.pdf

5. World Health Organization. Consolidated guidelines on HIV prevention testing treatment service delivery and monitoring: recommendations for a public health approach. Accessed June 3 2022. https://apps.who.int/iris/handle/10665/342899

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine learning aided multiscale modelling of the HIV-1 infection in the presence of NRTI therapy;PeerJ;2023-03-31

2. HIV Drug Resistance in Adults Initiating or Reinitiating Antiretroviral Therapy in Uruguay—Results of a Nationally Representative Survey, 2018–2019;Viruses;2023-02-10